1. Cutts, F.T et al. Human papillomavirus and HPV vaccines: a review.
Bulletin of the World Health Organization, WHO. 2007. 85(9): 649-732. Diakses melalui http://www.who.int/bulletin/volumes/85/9/06-038414/en/ pada tanggal 2 September 2016. 2. Institut Catala dOncologia.Human Papillomavirus and Related Diseases Report Human Papillomavirus and Related Diseases Report. 2016. 3. Khan, J.A. HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia. The New England Journal of Medicine, 2009. 361(3): 271-8. 4. Rahayu, A. S. Inveksi Human Papilloma Virus (HPV) dan Pencegahannya pada Remaja dan Dewasa Muda. Jurnal Biologi Papua, 2014. 2(2): 81-8 5. National Centre For Immunisation. Human Papillomavirus (HPV) Vaccines For Autralians : Informations For Immunisation Providers. 2016. 6. Brunicardi, F.C. et al. Schwartz Principles of Surgery Tenth Edition. McGraw-Hill Education. 2015. p: 485. 7. Leto, M,G,C. et al. Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. Bras Dermatol. 2011. 86(2):306-17. 8. Chow, L.T. et al. The natural history of human papillomavirus infections of the mucosal epithelia. The Authors Journal Compilation. 2011. 118:442-9. 9. ICO. Human Papillomavirus and Related Diseases Report Indonesia. Information Centre on HPV and Cancer. 2016. 10. JOGC. Canadian Consensus Guidelines on Human Paillomavirus. The Society of Obstetricians and Gynaecologist of Canada. 2007. 29(8): 12. 11. Moody, C.A, Laimonis, A.L. Human papillomavirus oncoproteins: pathways to transformation. Nature Reviews Cancer Macmillan Publishers Limited. USA. 2010. 10: 550-60. 12. Gomez, D,T. Juana Lopez Santos. Human Papillomavirus Infection And Cervical Cancer: Pathogenesis And Epidemiology. Communicating Current Research and Educational Topics and Trends in Applied Microbiology. 2007. p: 680-8. 13. Andrijono. Vaksinasi HPV Merupakan Pencegahan Primer Kanker Serviks. Majalah Kedokteran Indonesia. 2007. 57(5): 153-8. 14. Abbas AK, Litchman AH, Pillai S. Effector mechanisms of immune responses. Cellular and molecular immunology. 6th ed. Saunders, 2007 15. Tjhay, F. Risiko Infeksi Human Papilloma Virus (Hpv) Pada Penyakit Menular Seksual. Journal of Medicine. 2011. 10(1); 24-30. 16. Silva, K.C. et al. Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2009. 104(6); 885-91. 17. Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 2002;78:225-28. 18. Gottlieb S. Persistence of HPV increases risk of cervical cancer. Br Med J 2002;324:69 19. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Eng J Med 2005;353(20):2101-4.